Mechanistic studies consistently demonstrated that oxytocin modulates the key neural systems implicated in BPD, primarily by reducing amygdala hyperactivity, enhancing prefrontal–limbic connectivity, and decreasing the activity of the hypothalamic–pituitary–adrenal (HPA) axis. Here, OXT is linked to Borderline personality disorder.